Bentley InnoMed GmbH

Bentley InnoMed, founded in 2009, is offering doctors, patients and their partners innovative solutions for minimally invasive coronary as well as endovascular therapies.
Bentley InnoMed is working together with competent partners throughout the world to enhance the quality of life for the patients and their families. Scientists, engineers and doctors form an unbeatable network for bringing new technologies and exceptional products to the market.
The BeGraft Coronary Stent Graft System is distributed in more than 20 countries since June 2012. Besides the own products Bentley InnoMed offers a wide range of services like consultancy, development and manufacturing of medical devices and is aiming to be a reliable OEM partner for various solutions.
Bentley InnoMed is ISO 13485 certified. The integral Total Quality Management (TQM) approach improves the own high standards and requirements constantly.

Be innovative – we use advanced technologies to develop innovative and unique products
Be dedicated – through our customer focus and compliance to international standards we achieve superior product quality
Be responsible – our highly skilled and motivated team is engaged for the good of our patients
Be effective – we remain flexible to achieve our customer’s goals
100% Bentley InnoMed for patients and customers.